Filter posts

New Type of Prospective Survey Initiative

Our industry is on the cutting-edge of science aimed at developing new therapies for devastating …

Fact vs. Fear: Are GM Enzymes in Cheese Safe?

On June 6, 2014, Scientific American released an entertaining blog entitled “Genetically Modified Cheese… is …

BIO Testifies at 21st Century Cures Hearing on PCAST

Today, BIO’s Executive Vice President of Health Sara Radcliffe presented testimony to the U.S. House …

Driving Innovation through Federal Investments

Today, BIO submitted testimony to the Senate Committee on Appropriations on the importance of driving …

BIO Calls on Appropriators to Fully Fund FDA

BIO issued letters today encouraging support for programs and initiatives of critical importance to our …

“No Need to Label GMOs” Says FDA

The Nation’s Leading Regulatory Body on Food Safety Reaffirms Safety of GMOs On March 28, …

FDA: Vaccines a Critical Tool in Protecting and Promoting Public Health

Yesterday, Dr. Karen Midthun of the FDA wrote about the important role of vaccines in promoting public …

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, …

4 Tips for Building a Successful Biotech: Richard Pops of Alkermes at #BIOCEO14

The 16th Annual BIO CEO & Investor Conference opened with a fireside chat between Richard …

BIO Responds to GPhA Citizen Petition on Biosimilars Naming

Last September, the Generic Pharmaceutical Association (GPhA) filed a Citizen Petition with the FDA, requesting …